US Stock MarketDetailed Quotes

CLVLY CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV

Watchlist
  • 9.460
  • +0.380+4.19%
Close Mar 28 16:00 ET
474.20MMarket Cap24.26P/E (TTM)

About CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV Company

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.

Company Profile

SymbolCLVLY
Company NameCLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV
Founded1999
CEODr. Philippe J. Wolgen, M.B.A.,M.D.
MarketPink Market
Employees16
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
Address535 Bourke Street,Level 11
CityMelbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3000
Phone61-3-9660-4900

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Philippe J. Wolgen, M.B.A.,M.D.
  • Director, Managing Director and Chief Executive Officer
  • --
  • Willem A. Blijdorp
  • Chairman of the Board
  • --
  • Professor Sir. John Andrew Likierman
  • Independent Director
  • --
  • Brenda M. Shanahan
  • Independent Director
  • --
  • Dr. Karen Agersborg
  • Independent Director
  • --
  • Susan Smith
  • Independent Director
  • --
  • Professor Jeffrey Rosenfeld
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg